5 Urology studies in the library address this question.
“Analyses indicated statistically significant difference in ischemia time favoring RG (p = 0.045), with a mean difference of 3.8 minutes.”
Duarte 2026 · Randomized controlled trial · n: 45 patients
“Preoperative visualization of the iVR model resulted in a changed calyx of entry in 30% of cases.”
Cumpanas 2025 · Randomized controlled trial · n: 175 patients
“For urologists treating complex renal tumors, MR technology can help them reduce the warm ischemia time (21.3 ± 4.0 vs 23.6 ± 5.9 minutes, p = 0.031), reconstruction time (15.4 ± 3.8 vs 17.2 ± 4.2 minutes, p = 0.034)”
Yang 2022 · Randomized controlled trial · n: 92 patients
“In 32% of intervention cases, the surgeons modified their operative plan based on the model.”
Shirk 2022 · Randomized controlled trial · n: 92 patients
Study designs: 5 randomized trials.
Duarte DM Junior et al. · International braz j urol · 2026
Urology · Randomized controlled trial · n: 45 patients
“Analyses indicated statistically significant difference in ischemia time favoring RG (p = 0.045), with a mean difference of 3.8 minutes.”
p = 0.045
Cumpanas AD et al. · The Journal of urology · 2025
Urology · Randomized controlled trial · n: 175 patients
“Preoperative visualization of the iVR model resulted in a changed calyx of entry in 30% of cases.”
30%
Yang Y et al. · Journal of endourology · 2022
Urology · Randomized controlled trial · n: 92 patients
“For urologists treating complex renal tumors, MR technology can help them reduce the warm ischemia time (21.3 ± 4.0 vs 23.6 ± 5.9 minutes, p = 0.031), reconstruction time (15.4 ± 3.8 vs 17.2 ± 4.2 minutes, p = 0.034)”
p = 0.031
Shirk JD et al. · The Journal of urology · 2022
Urology · Randomized controlled trial · n: 92 patients
“In 32% of intervention cases, the surgeons modified their operative plan based on the model.”
32%
Shirk JD et al. · JAMA network open · 2019
Urology · Randomized controlled trial · n: 92 patients
“When controlling for case complexity and other covariates, patients whose surgical planning involved 3-D VR models showed differences in operative time (odds ratio [OR], 1.00; 95% CI, 0.37-2.70; estimated OR, 2.47), estimated blood loss (OR, 1.98; 95% CI, 1.04-3.78; estimated OR, 4.56), clamp time (OR, 1.60; 95% CI, 0.79-3.23; estimated OR, 11.22), and length of hospital stay (OR, 2.86; 95% CI, 1.59-5.14; estimated OR, 5.43).”
All urology studiesThis question across specialtiesBrowse the whole library
Summarises published research on VR/AR surgical planning across all platforms. Not product labelling. For Elucis indications see /elucis.
Intended for healthcare professionals.
Summaries and quotes describe each study's methods and the findings its authors report. They are not claims by Realize Medical and may contain errors: please read the original paper. Inclusion is not an endorsement of any product or use.